Japanese Real Estate Stock News

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Toami...

Readers hoping to buy Maruwn Corporation ( TSE:9067 ) for its dividend will need to make their move shortly, as the...

Murakami Corporation ( TSE:7292 ) stock is about to trade ex-dividend in four days. The ex-dividend date is commonly...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see CRI...

It looks like TOTO LTD. ( TSE:5332 ) is about to go ex-dividend in the next 4 days. The ex-dividend date is commonly...

The adish Co., Ltd. ( TSE:7093 ) share price has done very well over the last month, posting an excellent gain of 48...

Jefferies Financial Group and Sumitomo Mitsui Financial Group recently announced a major expansion of their global alliance, which includes a new joint venture for wholesale Japanese equities, plans for SMBC Group to increase its stake in Jefferies up to 20%, and the provision of approximately US$2.5 billion in new credit facilities to support their collaboration globally. This deepened alliance aims to leverage both partners’ strengths in global capital markets, enhancing offerings for...

If you have been following JVCKENWOOD (TSE:6632), you may have noticed the stock’s recent fluctuations catching the attention of investors. While there has been no specific event driving headlines, these price movements can lead to questions about whether something deeper is shifting beneath the surface. In markets where even subtle signals matter, it is no surprise to see owners and potential buyers alike starting to weigh their next move with renewed interest. Putting these shares in...

In recent news, Jefferies upgraded Pola Orbis Holdings Inc. from Underperform to Hold after observing stabilization in consignment sales and highlighting strong gross profit margins, improved profit contributions from non-Pola brands, and reduced U.S. risk exposure. This shift suggests analysts are responding to more positive operational signals and expectations for higher operating profit in the coming years. We’ll explore how the stabilization in consignment sales could influence Pola...

Marubeni (TSE:8002) is back in the spotlight after Warren Buffett’s Berkshire Hathaway revealed it had increased its stake in Mitsui & Co. above 10%. This signals the firm’s confidence in Japanese trading houses and reignites interest in the entire sector. The ripple effect was immediate, with Japanese trading firms, including Marubeni, seeing a boost in investor optimism as markets digested the possibility of further investments. It is one of those moments where, even without direct news...

Advantest Corporation recently announced the launch of its 7038 Single Test Rack (STR), a new system-level and burn-in test solution designed to meet the evolving thermal and complexity demands of AI, high-performance compute, and automotive device testing. This new product offers both air- and liquid-cooled thermal management options and a turnkey, single-vendor system for streamlined and risk-reduced deployment, specifically targeting the increasing power requirements and integration needs...

If you’re weighing what to do with Mitsui Mining & Smelting stock right now, you’re not alone. Investors have watched the stock stage an extraordinary rally lately, and the buzz is real. In just the past week, shares have climbed 7.5%, and the surge extends further, with gains of 11.4% over the last month and an astonishing 138.3% year-to-date performance. Looking back even further, Mitsui’s stock has returned a staggering 410.0% over five years. These head-turning numbers aren’t just luck...

Deciding what to do with Ichigo stock right now? You are not alone. Over the last few years, Ichigo has quietly posted solid returns that might surprise new investors. Just this year, shares are up nearly 15%, while the past twelve months have brought an impressive 18.7% gain. If you zoom out even further, the five-year performance stands at a strong 60.5%. Of course, that journey has not always been smooth. Last week saw a slight dip of 0.9%, but that minor setback hardly erases the...

Recently, analysts have significantly raised Mazda Motor Corporation's full-year earnings estimates, leading to an improved Zacks Rank of #2 (Buy) for the company. This marked revision indicates rising confidence in Mazda's earnings outlook, with analyst sentiment much stronger over the past quarter. We'll explore how the sharp upward adjustment in earnings forecasts impacts Mazda's broader investment narrative and future growth prospects. The latest GPUs need a type of rare earth metal...

Deciding what to do with Kirin Holdings Company stock these days can feel a bit like standing at a crossroads, with opportunity just around the corner and questions about value lingering in the air. If the last few months are any indication, investors who have held on are seeing signs that the market is taking notice of Kirin’s potential. Over the past week, the stock is up 2.7%, and it has inched upward by 8.3% since the start of the year. Even over the longer term, Kirin’s shares have...

If you have been watching HASEKO’s share price lately, you might be wondering whether it is still a smart place to put your money or if most of the gains are already reflected in the price. With the stock recently closing at 2,500 yen, some investors are debating whether the remarkable run can continue. Over the last year alone, HASEKO shares have climbed 36.8%, and the gains appear even more impressive when looking at a five-year return of 124.6%. Even short-term performance has remained...

If you find yourself debating what to do with Kao stock, you are definitely not alone. The past year has been a bit of a rollercoaster for Kao investors, with the stock sliding 3.3% over twelve months and nudging downward by 2.5% in just the last week. Yet, if we zoom out a bit, there are signs of resilience. Year-to-date, shares are up 3.9%, and over a three-year stretch, Kao is actually sitting on a tidy gain of 20.6%. It is a picture that mixes long-term growth potential with recent market...

If you have been keeping an eye on Sumitomo Rubber Industries, you are probably wondering whether it's time to jump in, stay the course, or lock in some profits. The stock has recently given investors plenty to talk about. After notching a solid 124.2% gain over the last five years and an impressive 67.0% rise in the past three, this tire powerhouse has shown it’s capable of delivering long-term growth. Even more recently, the stock is up 13.7% over the past year, with a steadier 1.6% return...

Are you standing at the crossroads, trying to figure out whether Nissin Foods HoldingsLtd deserves a place in your portfolio? You are not alone. This well-known player in the packaged foods industry has delivered more than a few surprises for investors in recent years, so it's only natural to ask whether the current market price really reflects its value. Looking at its recent share price performance, Nissin has not exactly been a highflier lately. The stock closed at 2,880.0, with returns of...

If you have been keeping an eye on Yamaha's stock lately, you are probably wondering whether now is the right moment to take action or to stay on the sidelines. Over the past few years, Yamaha’s share price has certainly tested the patience of long-term investors. Despite brief moments of recovery, the stock has slipped by 17.9% over the last year and by more than 35% over the past three and five years. That paints a picture of persistent market skepticism, or perhaps shifting risk...

In September 2025, Astellas Pharma announced that Japan's Ministry of Health, Labor and Welfare granted conditional approval for IZERVAY (avacincaptad pegol) as the first and only treatment for geographic atrophy in age-related macular degeneration. This expedited approval, based on significant reductions in lesion growth during global trials, positions Astellas to fill an important gap for patients facing serious unmet medical needs in Japan. We'll take a look at how bringing the first GA...

If you are weighing your next move with Calbee shares, you are far from alone. Investors have watched the stock’s price zig-zag over recent months, and it is natural to wonder if opportunity or risk lies ahead. Over the last 30 days, Calbee climbed by 5.3%, reversing some of this year’s loss. Yet, it is still down 5.6% year to date and off 11.4% for the past 12 months. The slight drop in the past week, at -2.7%, hints at ongoing volatility as broader Japanese market sentiment reacts to...

If you’re wondering whether Japan Post Insurance is still a smart place to put your money, you’re definitely not alone. After all, the stock has been on quite a journey lately. After dipping slightly by 1.7% over the last week and 1.5% over the past month, you might wonder if enthusiasm is waning. However, looking at a broader time frame gives things an entirely different feel. Year to date, Japan Post Insurance shares are up a remarkable 40.0%, with a 62.0% gain over the last year and a...

Ono Pharmaceutical recently announced that the European Commission has approved ROMVIMZA™ (vimseltinib) to treat adult patients in the EU with symptomatic tenosynovial giant cell tumor (TGCT) where surgical options are limited. This regulatory milestone offers Ono Pharmaceutical expanded access to the EU market, supported by robust clinical data showing meaningful improvements for patients. We’ll explore how this important regulatory approval and expanded European patient access shapes the...